[Copolymer 1 in therapy of multiple sclerosis].
Weilbach
F X
FX
Klinische Forschungsgruppe für Multiple Sklerose, Julius-Maximilians-Universität Würzburg.
Voltz
R
R
Hohlfeld
R
R
Hartung
H P
HP
D000293:Adolescent; D000328:Adult; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D004676:Myelin Basic Protein / Q000276:immunology; D009460:Neurologic Examination / Q000187:drug effects; D010455:Peptides / Q000009:adverse effects / Q000627:therapeutic use*; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic
D004676:Myelin Basic Protein; D010455:Peptides; D000068717:Glatiramer Acetate